Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Dyslipidemia

  Free Subscription


Articles published in Am J Med

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    April 2022
  1. WYLIE LE, Waterbrook AL, Dalen JE
    Are Statins Indicated in Senior Citizens? A Review of Statin Therapy in the Elderly.
    Am J Med. 2022;135:426-429.
    PubMed     Abstract available


  2. MAROGI EP, Ohiomoba RO, Stone NJ
    Eruptive Xanthomas: Importance of Recognition to Reduce Delay of Effective Triglyceride Reduction.
    Am J Med. 2022;135:444-447.
    PubMed     Abstract available


    March 2022
  3. LOPES RD, Guimaraes PO, Schwartz GG, Bhatt DL, et al
    Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Randomized Trial.
    Am J Med. 2022 Mar 13. pii: S0002-9343(22)00173.
    PubMed     Abstract available


    February 2022
  4. FUJIKAWA T, Sogabe Y
    Lipid Metabolic Disorder with Varied Clinical Manifestations.
    Am J Med. 2022;135:e42-e43.
    PubMed    


    January 2022
  5. GUPTA M, Liti B, Barrett C, Thompson PD, et al
    Prevention and Management of Hypertriglyceridemia-Induced Acute Pancreatitis during Pregnancy: A Systematic Review.
    Am J Med. 2022 Jan 23. pii: S0002-9343(22)00039.
    PubMed     Abstract available


    May 2021
  6. HOCH VL, Lin KH, Soffer D, Stone NJ, et al
    A "rule of thumb" aids evaluation of severe hypercholesterolemia to recognize familial hypercholesterolemia.
    Am J Med. 2021 May 25. pii: S0002-9343(21)00328.
    PubMed    


    April 2021
  7. DENBY KJ, Cho L, Toljan K, Patil M, et al
    Assessment of Cardiovascular Risk in Transgender Patients Presenting for Gender-Affirming Care.
    Am J Med. 2021 Apr 22. pii: S0002-9343(21)00215.
    PubMed     Abstract available


  8. ELBADAWI A, Elgendy IY, Omer M, Abdelazeem M, et al
    Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia.
    Am J Med. 2021 Apr 16. pii: S0002-9343(21)00226.
    PubMed     Abstract available


  9. MASON RP, Eckel RH
    Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk Reduction.
    Am J Med. 2021 Apr 14. pii: S0002-9343(21)00227.
    PubMed     Abstract available


  10. OMELCHENKO A, Hornik-Lurie T, Gabay H, Minha S, et al
    LDL Cholesterol and Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation.
    Am J Med. 2021;134:507-513.
    PubMed     Abstract available


  11. LEE MT, Mahtta D, Chen L, Hussain A, et al
    Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease.
    Am J Med. 2021 Apr 1. pii: S0002-9343(21)00213.
    PubMed     Abstract available


    February 2021
  12. BAE SS, Chang LC, Merkin SS, Elashoff D, et al
    Major Lipids and Future Risk of Pneumonia: 20-Year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort.
    Am J Med. 2021;134:243-251.
    PubMed     Abstract available


    January 2021
  13. ARBEL R, Aboalhasan E, Hammerman A, Azuri J, et al
    Icosapent Ethyl for Primary Versus Secondary Prevention of Major Adverse Cardiovascular Events in Hypertriglyceridemia-Value for Money Analysis.
    Am J Med. 2021 Jan 12. pii: S0002-9343(21)00021.
    PubMed     Abstract available


    November 2020
  14. ALDER M, Bavishi A, Zumpf K, Peterson J, et al
    A Meta-Analysis Assessing Additional LDL-C Reduction from Addition of a Bile Acid Sequestrant to Statin Therapy.
    Am J Med. 2020;133:1322-1327.
    PubMed     Abstract available


    April 2020
  15. CLAXTON JS, Chamberlain AM, Lutsey PL, Chen LY, et al
    Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 years and older with Atrial Fibrillation.
    Am J Med. 2020 Apr 19. pii: S0002-9343(20)30344.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: